Serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in large cohorts of healthy adults. 1992

F E Weller, and U Shah, and G D Cummings, and P B Chretien, and M G Mutchnick
Department of Medicine, Wayne State University School of Medicine, Detroit, MI 48201.

Enzyme linked immunosorbent assays were used to measure serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in 681 healthy adults (range 18 yr-101 yr). Immunoreactive thymosin alpha 1 was found to occur at a geometric mean of 540 pg/ml with a range from 252 to 1158 pg/ml. There were no differences in the levels when analyzed according to race, sex or age. Immunoreactive thymosin beta 4 was measured at a geometric mean of 12.6 ng/ml with a range from 6.9 to 23.0 ng/ml. There were no differences in the levels when analyzed according to race or sex, however, there was a slight upward trend with increasing age. This data may be useful as a reference when monitoring clinical studies, determining the kinetics of drug metabolism and distinguishing patient groups with elevated levels of either of these peptides.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077596 Thymalfasin A thymus hormone polypeptide found in thymosin fraction 5 (a crude thymus gland extract) but now produced by synthesis. It is used alone or with interferon as an immunomodulator for the treatment of CHRONIC HEPATITIS B and HEPATITIS C. Thymalfasin is also used for the treatment of chemotherapy-induced immunosuppression, and to enhance the efficacy of influenza and hepatitis B vaccines in immunocompromised patients. Thymosin alpha(1),Thymosin alpha1,Zadaxin,alpha1-Thymosin,alpha1 Thymosin
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

F E Weller, and U Shah, and G D Cummings, and P B Chretien, and M G Mutchnick
January 1986, International journal of immunopharmacology,
F E Weller, and U Shah, and G D Cummings, and P B Chretien, and M G Mutchnick
July 2018, Expert opinion on biological therapy,
F E Weller, and U Shah, and G D Cummings, and P B Chretien, and M G Mutchnick
December 1993, The Journal of thoracic and cardiovascular surgery,
F E Weller, and U Shah, and G D Cummings, and P B Chretien, and M G Mutchnick
January 1989, Lymphokine research,
F E Weller, and U Shah, and G D Cummings, and P B Chretien, and M G Mutchnick
January 1990, Immunopharmacology,
F E Weller, and U Shah, and G D Cummings, and P B Chretien, and M G Mutchnick
April 1988, Clinical immunology and immunopathology,
F E Weller, and U Shah, and G D Cummings, and P B Chretien, and M G Mutchnick
February 1985, Analytical biochemistry,
F E Weller, and U Shah, and G D Cummings, and P B Chretien, and M G Mutchnick
January 1985, Methods in enzymology,
F E Weller, and U Shah, and G D Cummings, and P B Chretien, and M G Mutchnick
June 1998, Acta medica Okayama,
F E Weller, and U Shah, and G D Cummings, and P B Chretien, and M G Mutchnick
October 1992, International journal of immunopharmacology,
Copied contents to your clipboard!